By 8–10 weeks, primary and metastatic tumor cells were mostly AR− and ASCL1+ with heterogenous KRT8 and E-cadherin expression (Figs. 3b and 5b and Extended Data Figs. 3e,f and 5a). The gene discussed is KRT8; the disease is neoplasm.